HAEMATO AG (HMSE: HAEK)
Health Care · Health Care Providers & Services · DE
€12.70
-3.05% today · +24.5% 1Y
HAEMATO AG (HMSE: HAEK) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $77.50M and employs 76 people.
Over the last twelve months the share price has gained 24.5%, trading between 8.20 and 13.60.
Tweenvest scores HAEMATO AG across four factors: quality 71/100, value 46/100, growth 51/100. Its strongest factor is quality.
HAEK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $77.50M
- Revenue (TTM)
- $284.72M
- P/E
- 6.77
- EPS
- 1.88
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- €13.60
- 52-week low
- €8.20
- Avg volume (3M)
- —
- Shares outstanding
- 5.23M
- Employees
- 76
- Next earnings
- —
About HAEMATO AG
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
- ISIN
- DE000A289VV1
- Founded
- 1993
- Listed since
- Dec 28, 2007
- Exchange
- Hamburg Stock Exchange
- Currency
- EUR
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $396.59 | -0.54% |
| CVS Health CorporationNYSE: CVS | $118.82B | $92.90 | -1.29% |
| McKesson CorporationNYSE: MCK | $105.52B | $905.09 | +3.58% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $428.76 | -0.11% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $398.87 | -0.93% |
| The Cigna GroupNYSE: CI | $73.81B | $279.32 | -0.40% |
| Cencora, Inc.NYSE: COR | $62.60B | $328.06 | +1.33% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $237.92 | +2.39% |
Figures last refreshed Aug 18, 2026.